Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 August 2008

Ann Rheum Dis. Published Online First: 2 April 2008. doi:10.1136/ard.2008.088138
Copyright © 2008 BMJ Publishing Group Ltd & European League Against Rheumatism.

Concise Report

The TNF Receptor Superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis

Erik J.M. Toonen 1, Marieke J.H. Coenen 1*, Wietske Kievit 2, Jaap Fransen 1, Agnes M.M. Eijsbouts 3, Hans Scheffer 1, Timothy R.D.J. Radstake 4, Marjonne C.W. Creemers 2, Dirk-Jan R.A.M. de Rooij 3, Piet L.C.M. van Riel 4, Barbara Franke 4 and P Barrera 2

1 Radboud University Nijmegen Medical Centre, Netherlands
2 UMC Nijmegen, Netherlands
3 St Maartenskliniek Nijmegen, Netherlands
4 University Medical Center Nijmegen, Netherlands

* To whom correspondence should be addressed. E-mail: m.coenen{at}antrg.umcn.nl.

Accepted 24 March 2008


Abstract

Objective: The purpose of this study was to assess the effect of a functional polymorphism (676T>G, M196R) in the Tumor Necrosis Factor Receptor super family 1b (TNFSF1b) gene on disease activity, radiologic joint damage and response to infliximab and adalimumab therapy in patients with rheumatoid arthritis (RA).

Methods: Two RA patient cohorts were genotyped for the 676T>G polymorphism (rs1061622) in exon 6 of the TNFSF1b gene by restriction fragment length polymorphism analysis. One cohort (n=234) included patients from the Dutch Rheumatoid Arthritis Monitoring (DREAM) register with detailed information on their response to anti-TNF therapy (infliximab and adalimumab), the other concerned patients from a long-term observational early inception cohort at our center (n=248).

Results: The 676T>G polymorphism was not associated with anti-TNF response after three or six months of therapy. Linear regression analysis showed no significant difference in the progression of radiologic joint damage during the first three and six years of disease between the three genotype groups (TT, TG and GG). No difference in mean disease activity between genotypes was observed after three and six years of disease, either.

Conclusion: Despite its demonstrated functionality, the 676T>G polymorphism in the TNFSF1b gene does not play a major role in either the response to anti-TNF therapy or in the disease severity or radiologic progression in RA.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Coenen, M. J.H., Trynka, G., Heskamp, S., Franke, B., van Diemen, C. C., Smolonska, J., van Leeuwen, M., Brouwer, E., Boezen, M. H., Postma, D. S., Platteel, M., Zanen, P., Lammers, J.-W. W.J., Groen, H. J.M., Mali, W. P.T.M., Mulder, C. J., Tack, G. J., Verbeek, W. H.M., Wolters, V. M., Houwen, R. H.J., Mearin, M. L., van Heel, D. A., Radstake, T. R.D.J., van Riel, P. L.C.M., Wijmenga, C., Barrera, P., Zhernakova, A. (2009). Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet 18: 4195-4203 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs